View Older Stories View More Recent Stories

Jan 4, 2022 07:30AM 9 Meters Biopharma, Inc. to Participate in the following Virtual January Investor Conferences
Jan 3, 2022 07:35AM 9 Meters Biopharma (NMTR) Appoints Sarah Liu as CCO, Al Medwar as Senior Vice President of Investor Relations & Corporate Communications
Jan 3, 2022 07:30AM 9 Meters Biopharma Appoints Sarah Liu as Chief Commercial Officer and Al Medwar as Senior Vice President of Investor Relations & Corporate Communications
Dec 15, 2021 07:30AM 9 Meters Biopharma, Inc. Awards Unrestricted Educational Grant Funding to Carol Rees Parrish, M.S., RDN, for Short Bowel Syndrome Education
Nov 15, 2021 07:30AM 9 Meters Biopharma Provides Business Update and Reports Financial Results for the Third Quarter 2021
Nov 10, 2021 07:32AM 9 Meters Biopharma (NMTR) Announces Immuno-Oncology Collaboration with Gustave Roussy for NM-102, a Gut Microbiome Modulator
Nov 10, 2021 07:30AM 9 Meters Biopharma, Inc. Announces Immuno-Oncology Collaboration with Gustave Roussy for NM-102, a Gut Microbiome Modulator
Nov 9, 2021 07:30AM 9 Meters Biopharma, Inc. to Present at the 12th Annual Jefferies London Healthcare Conference
Oct 26, 2021 07:36AM 9 Meters Biopharma (NMTR) Reports Pharmacokinetic Data from Phase 1b/2a Study with Vurolenatide
Oct 26, 2021 07:30AM 9 Meters Biopharma, Inc. Presents Pharmacokinetic Data from Phase 1b/2a Study with Vurolenatide, Currently in Phase 2 for Short Bowel Syndrome, at the American College of Gastroenterology (ACG) 2021
Oct 19, 2021 07:30AM 9 Meters Biopharma, Inc. to Present Data on Therapeutic Candidate in Short Bowel Syndrome at the American College of Gastroenterology (ACG) 2021 Annual Scientific Meeting
Oct 4, 2021 07:32AM 9 Meters Biopharma (NMTR) Appoints Samantha Ventimiglia to its Board
Oct 4, 2021 07:30AM 9 Meters Biopharma, Inc. Appoints Samantha Ventimiglia to Board of Directors
Sep 27, 2021 07:30AM 9 Meters Biopharma, Inc. Announces Partnership with Non-Profit Gluten-Free Food Pantry Organization Mend Hunger
Sep 22, 2021 08:15AM 9 Meters Biopharma, Inc. to Present at the Cantor Virtual Global Healthcare Conference
Sep 15, 2021 08:15AM 9 Meters Biopharma, Inc. to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
Sep 8, 2021 08:15AM 9 Meters Biopharma, Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
Sep 1, 2021 08:15AM 9 Meters Biopharma, Inc. to Participate in Citi's 16th Annual BioPharma Virtual Conference 2021
Aug 16, 2021 08:19AM 9 Meters Biopharma (NMTR) Announces Collaboration with EBRIS Foundation for Planned Phase 2 Study of Larazotide for the Treatment of MIS-C Resulting from COVID-19
Aug 16, 2021 08:15AM 9 Meters Biopharma, Inc. Announces Collaboration with EBRIS Foundation for Planned Phase 2 Study of Larazotide for the Treatment of Multisystem Inflammatory Syndrome in Children (MIS-C) Resulting from
Aug 12, 2021 08:30AM 9 Meters Biopharma Provides Business Update and Reports Financial Results for the Second Quarter 2021
Aug 5, 2021 08:30AM 9 Meters Biopharma, Inc. to participate in BMO Capital Markets' "Biopharma Spotlight Series: Innovation in GI"
Jul 19, 2021 08:32AM 9 Meters Biopharma (NMTR) Announces Acquisition of Humanized Anti-GIP Monoclonal Antibody from Lobesity
Jul 19, 2021 08:30AM 9 Meters Biopharma, Inc. Announces the Acquisition of Humanized Anti-GIP Monoclonal Antibody from Lobesity
Jul 8, 2021 07:30AM 9 Meters Biopharma, Inc. To Present at the William Blair Biotech Focus Conference
Jun 28, 2021 07:30AM 9 Meters Added to Russell 2000(R) and 3000(R) Indexes
Jun 14, 2021 07:30AM 9 Meters Announces Initiation of Phase 2 VIBRANT Study of Vurolenatide for Short Bowel Syndrome
Jun 9, 2021 07:30AM 9 Meters Biopharma, Inc. to Present at 2021 BIO Digital
Jun 1, 2021 07:30AM 9 Meters Biopharma, Inc. to Present at the Jefferies Virtual Healthcare Conference
May 26, 2021 08:33AM 9 Meters Biopharma (NMTR) Announces Publication in Journal of Clinical Investigation Describing Successful Use of Larazotide for Treating Multisystem Inflammatory Syndrome in Children (MIS-C) resultin
May 26, 2021 08:30AM 9 Meters Biopharma, Inc. Announces Publication in Journal of Clinical Investigation Describing Successful Use of Larazotide for Treating Multisystem Inflammatory Syndrome in Children (MIS-C) resulting
May 18, 2021 10:15AM CORRECTION 9 Meters Biopharma, Inc. to Present at Oppenheimer's Rare & Orphan Disease Summit
May 18, 2021 07:30AM 9 Meters Biopharma, Inc. to Present at Oppenheimer's Rare & Orphan Disease Summit
May 17, 2021 07:33AM 9 Meters Biopharma (NMTR) Receives USAN Approval to Use the Designated Nonproprietary Name Vurolenatide for Its Long-Acting GLP-1 Agonist for Short Bowel Syndrome
May 17, 2021 07:30AM 9 Meters Biopharma, Inc. Receives USAN Approval to Use the Designated Nonproprietary Name Vurolenatide for Its Long-Acting GLP-1 Agonist for Short Bowel Syndrome
May 13, 2021 07:30AM 9 Meters Biopharma Provides Business Update and Reports Financial Results for the First Quarter 2021
Apr 21, 2021 07:30AM 9 Meters Biopharma, Inc. to Participate in the Truist Securities 7th Annual Life Sciences Summit
Apr 19, 2021 07:37AM 9 Meters Biopharma (NMTR) Announces Collaboration with the Duke Clinical Research Institute to Support 9 Meters' Program in Short Bowel Syndrome
Apr 19, 2021 07:30AM 9 Meters Biopharma, Inc. Announces Collaboration with the Duke Clinical Research Institute to Support 9 Meters' Program in Short Bowel Syndrome
Apr 12, 2021 07:36AM 9 Meters Biopharma (NMTR) and Celiac Disease Foundation Report Collaboration to Support Clinical Trial Enrollment in 9 Meters' Phase 3 CeDLara Study
Apr 12, 2021 07:30AM 9 Meters Biopharma, Inc. and Celiac Disease Foundation Announce Collaboration to Support Clinical Trial Enrollment in 9 Meters' Phase 3 CeDLara Study
Mar 30, 2021 04:33PM 9 Meters Biopharma (NMTR) Announces Proposed Public Offering of Common Stock
Mar 30, 2021 04:14PM 9 Meters Biopharma Announces Proposed Public Offering of Common Stock
Mar 22, 2021 04:00PM 9 Meters Biopharma Provides Business Update and Reports Financial Results for the Fourth Quarter and Full Year 2020
Mar 15, 2021 07:30AM 9 Meters Biopharma Hosting Key Opinion Leader Webinar on Short Bowel Syndrome and NM-002 Program Update
Mar 10, 2021 07:30AM 9 Meters Biopharma, Inc. to Participate in the following Virtual March Investor Conferences
Mar 9, 2021 07:30AM 9 Meters Biopharma, Inc. Announces Chief Medical Officer's Presentation at NIH's Accelerating Progress in Celiac Disease Workshop
Mar 1, 2021 07:40AM ​9 Meters Biopharma (NMTR) Appoints Michael Rice to Board of Directors
Mar 1, 2021 07:30AM 9 Meters Biopharma, Inc. Appoints Michael Rice to Board of Directors
Feb 10, 2021 07:30AM 9 Meters Biopharma, Inc. to Present at the 23rd Annual BIO CEO & Investor Conference
View More Recent Stories View Older Stories